diacarta产品代理
diacarta产品代理
DiaCarta 是一家转化基因组学和精准分子诊断公司，成立于 2011 年，旨在提供高度敏感和先进的技术，以改善分子诊断和转化基因组学对医疗保健治疗计划和世界各地个人福祉的影响方式。 DiaCarta 拥有 80 多项全球专利，提供一系列产品和服务，从单基因癌症突变检测 qPCR 检测、结直肠癌突变检测面板、放射治疗毒性监测 cfDNA 测试到其靶向 NGS 面板。
拥有超过 27,000 平方英尺的专门用于符合 GMP 的实验室空间以及 CLIA 和 ISO 13485 认证，在南京设有临床实验室设施，并在中国上海设有办事处。 DiaCarta 设备齐全，可为世界各地的临床实验室提供服务。位于中国南京的 DiaCarta 临床服务实验室是世界上最大的测序中心，拥有多种精密的测序仪器。公司目前正在参与“百万基因组计划”，计划对100万中国人进行全基因组测序（WGS）。
DiaCarta is Changing the Landscape of Precision Molecular Diagnostics
DiaCarta, a translational genomics and precision molecular diagnostics company, was established in 2011 to provide highly sensitive and advanced technologies that will improve the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. With over 80 global patents, DiaCarta offers a range of products and services, from single-gene cancer mutation detection qPCR assays, colorectal cancer mutation detection panels, radiation therapy toxicity monitoring cfDNA test to its targeted NGS panels.
With over 27,000 square feet dedicated to a GMP-compliant
lab space as well as CLIA and ISO 13485 certifications, a clinical laboratory facility in Nanjing, and offices in Shanghai, China. DiaCarta is well-equipped to serve clinical laboratories around the world. DiaCarta’s Clinical Service Lab at Nanjing, China is the world’s largest sequencing center housing several sophisticated sequencing instruments. The company is currently involved in the “One-Million Genome Project”, with plans to conduct Whole Genome Sequencing (WGS) on one million Chinese individuals.
